Rights and permissions
About this article
Cite this article
Switch to generic SSRIs may boost costs in MDD. Pharmacoecon. Outcomes News 625, 7 (2011). https://doi.org/10.2165/00151234-201106250-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106250-00022